Results 71 to 80 of about 14,818 (181)
Controversies about Extended-Spectrum and AmpC Beta-Lactamases [PDF]
Many clinical laboratories have problems detecting extended-spectrum beta-lactamases (ESBLs) and plasmid-mediated AmpC beta-lactamases. Confusion exists about the importance of these resistance mechanisms, optimal test methods, and appropriate reporting conventions.
openaire +3 more sources
This review introduces the development and classification of all‐nanozyme cascade reaction systems, highlighting mechanistic insights and research methods for understanding catalytic features and design principles. It provides detailed classifications, surveys recent applications in biosensing and therapy, and discusses the challenges that all‐nanozyme
Caixia Zhu +4 more
wiley +1 more source
Introduction: Extended-spectrum beta-lactamase (ESBL) and AmpC beta-lactamase (AmpC-BL) in Enterobacteriaceae are a global threat. Coproduction of AmpC-BL and ESBL reduces therapeutic options, with more resistance against cephamycin and beta-lactamase ...
Mohammad Agung Marzah +10 more
doaj +1 more source
Extended-Spectrum-β-Lactamase, AmpC, and Carbapenemase Issues [PDF]
Optimal use of microbiology laboratories is essential to combat the spread of multiply antibiotic-resistant pathogens. This is vital for patient care, as advocated by Jarvis in stressing the importance of active detection and isolation to control methicillin-resistant Staphylococcus aureus and other resistant hospital-acquired pathogens (17).
openaire +2 more sources
Abstract Purpose To examine the association of hypothyroidism with primary total knee arthroplasty (TKA) outcomes in adults with primary underlying diagnosis of osteoarthritis (OA). Methods We identified a prospective cohort of patients in the 2016–2020 national inpatient sample (NIS) that received primary TKA with an underlying diagnosis of OA ...
Sumanth R. Chandrupatla +2 more
wiley +1 more source
Aim: This study aimed to identify Gram-negative uropathogens (GN-UP)-producing extended-spectrum beta-lactamases (ESBL), metallo-beta-lactamases (MBL), and AmpC enzymes in diabetic patients and to analyze their antibiotic resistance profiles.
Satish R Patil +3 more
doaj +1 more source
Here we report a case of PVL‐negative MSSA necrotizing pneumonia in a previously healthy man that rapidly progressed to cavitary lesions and refractory pneumothorax. Despite its improvement after clindamycin‐based therapy, the patient experienced recurrent pneumothorax and chronic respiratory failure.
Shun Endo +4 more
wiley +1 more source
AmpC induction by ceftaroline [PDF]
Mushtaq, Shazad, Livermore, David M
openaire +3 more sources
Correlation between the mutation rates for ampC derepression and species or ampC genotypes in Enterobacter cloacae complex. [PDF]
Abstract Background In this study, we investigated the correlation between the mutation rates for ampC derepression and species or ampC genotypes in Enterobacter cloacae complex (ECC) susceptible to ceftriaxone. Non-duplicate ceftriaxone-sensitive ECC isolates (90) were obtained from September 2021 to January 2023 at ...
Xie L, Wu Y, Huang Q, Sun J.
europepmc +2 more sources
Two pairs of ceftolozane/tazobactam susceptible/resistant P. aeruginosa were isolated from 2 patients after exposure to β-lactams. The genetic basis of ceftolozane/tazobactam resistance was evaluated, and β-lactam-resistant mechanisms were assessed by phenotypic assays. Whole genome sequencing identified mutations in AmpC including the mutation (V213A)
Erik Skoglund +11 more
openaire +3 more sources

